XML 21 R5.htm IDEA: XBRL DOCUMENT v3.19.2
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Shares outstanding, beginning balance (in shares) at Dec. 31, 2017   47,236,103    
Beginning balance at Dec. 31, 2017 $ 11,865,099 $ 31,459 $ 234,438,057 $ (222,604,417)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of common stock (in shares)   4,064,310    
Issuance of common stock $ 1,185,452 $ 2,707 1,182,745  
Common stock issuance costs (in shares) 615,605      
Common stock issuance costs $ (52,568) $ 410 (52,978)  
Purchase of membership interest (in shares)   1,475,410    
Purchase of membership interests 0 $ 983 (983)  
Net loss (2,484,903)     (2,484,903)
Shares outstanding, ending balance (in shares) at Mar. 31, 2018   53,391,428    
Ending balance at Mar. 31, 2018 10,513,080 $ 35,559 235,566,841 (225,089,320)
Shares outstanding, beginning balance (in shares) at Dec. 31, 2017   47,236,103    
Beginning balance at Dec. 31, 2017 11,865,099 $ 31,459 234,438,057 (222,604,417)
Shares outstanding, ending balance (in shares) at Dec. 31, 2018   75,338,273    
Ending balance at Dec. 31, 2018 9,384,902 $ 50,175 241,419,897 (232,085,170)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of common stock (in shares)   5,452,000    
Issuance of common stock 813,561 $ 3,631 809,930  
Common stock issuance costs (85,093)   (85,093)  
Net loss (1,835,065)     (1,835,065)
Shares outstanding, ending balance (in shares) at Mar. 31, 2019   80,790,273    
Ending balance at Mar. 31, 2019 $ 8,278,305 $ 53,806 $ 242,144,734 $ (233,920,235)